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Abstract Digital PCR (dPCR) is beginning to supersede
real-time PCR (qPCR) for quantification of nucleic acids
in many different applications. Several analytical proper-
ties of the two most commonly used dPCR platforms,
namely the QX100 system (Bio-Rad) and the 12.765 ar-
ray of the Biomark system (Fluidigm), have already been
evaluated and compared with those of qPCR. However, to
the best of our knowledge, direct comparison between the
three of these platforms using the same DNA material has
not been done, and the 37 K array on the Biomark system
has also not been evaluated in terms of linearity, analyti-
cal sensitivity and limit of quantification. Here, a first
assessment of qPCR, the QX100 system and both arrays
of the Biomark system was performed with plasmid and
genomic DNA from human cytomegalovirus. With use of
PCR components that alter the efficiency of qPCR, each
dPCR platform demonstrated consistent copy-number es-
timations, which indicates the high resilience of dPCR.
Two approaches, one considering the total reaction vol-
ume and the other considering the effective reaction size,
were used to assess linearity, analytical sensitivity and
variability. When the total reaction volume was consid-
ered, the best performance was observed with qPCR,
followed by the QX100 system and the Biomark system.
In contrast, when the effective reaction size was consid-
ered, all three platforms showed almost equal limits of
detection and variability. Although dPCR might not al-
ways be more appropriate than qPCR for quantification
of low copy numbers, dPCR is a suitable method for ro-
bust and reproducible quantification of viral DNA, and a
promising technology for the higher-order reference mea-
surement method.
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Introduction
Real-time PCR (qPCR) is a PCR-based method for quan-
tification of nucleic acids. Owing to its dominant perfor-
mance over other quantification methods in terms of accu-
racy, specificity, repeatability and dynamic range, qPCR is
routinely used for various applications in agriculture, med-
icine, molecular diagnostics, forensic testing and testing of
genetically modified organisms [1]. In recent years, a novel
version of PCR, known as digital PCR (dPCR), has be-
come widely used in the field of nucleic acid quantifica-
tion. Digital PCR (dPCR) uses limiting dilutions and sam-
ple partitioning into sub-microlitre reactions to achieve
sensitive, precise, accurate, reliable and reproducible quan-
tification of nucleic acids. In contrast to analogue qPCR,
where the amplification signal is logarithmic and the quan-
tification is based on external calibration, dPCR offers sim-
ple, linear and digital quantification that is based only on
the number of positive and negative reactions, with the
Poisson distribution taken into account [2, 3]. Digital
PCR (dPCR) has additional advantages over qPCR, as it
has been reported to be more tolerant to some PCR inhib-
itors, sequence variations and different types of DNA tem-
plates, PCR assays and master mixes [2, 4–6]. Although
there are some limitations of dPCR owing to the restricted
reaction volume, which can result in lower analytical sen-
sitivity compared with qPCR [7–9], dPCR offers high re-
peatability even when measuring low DNA concentrations
[2, 9, 10]. Because of these benefits of dPCR, it has great
potential and has already been used for many different appli-
cations, such as for plant pathogens and testing of genetically
modified organisms, detection of resistant bacteria, viral diag-
nostics, rare-mutant detection and copy-number variations
[11–16].
This digital format (i.e., dPCR) is achieved either by a
microfluidic-based approach, where a reaction is divided into
hundreds or thousands of chambers on a single plate or array,
or by a droplet-based approach, where a reaction is separated
into thousands or millions of droplets [8]. Despite the avail-
ability of several different dPCR platforms, most studies have
been performed either with the microfluidic-based Biomark™
HD system (Fluidigm) [2, 6, 17] or with the droplet-based
QX100™ Droplet Digital™ PCR system (Bio-Rad) and the
QX200™ Droplet Digital™ PCR system (Bio-Rad) [18–20].
Although many analytical characteristics of the QX100 sys-
tem and the 12.765 Digital Array™ integrated fluidic circuit
(Fluidigm) on the Biomark system have already been deter-
mined and compared with those of qPCR [2, 5, 9], to the best
of our knowledge, no assessment of the qdPCR 37 K™ inte-
grated fluidic circuit (Fluidigm) on the Biomark system in
terms of linearity, analytical sensitivity and limit of quantifi-
cation (LOQ) has been performed, although it offers high-
throughput analysis. Additionally, only a few studies have
focused on systematic direct comparisons between qPCR
and both of these dPCR platforms using the same DNA ma-
terial. Also, for each dPCR platform, the influence of different
PCR components on DNA quantification has been poorly
studied.
Here, qPCR and the two dPCR platforms, the QX100 sys-
tem and the Biomark system (using the 12.765 array and the
37 K array), were assessed with use of clinically relevant
concentrations of two reference materials for human cytomeg-
alovirus (HCMV), one of which contained circular plasmid
DNA, and the other contained linear genomic DNA (gDNA)
(Fig. 1). For the QX100 system and for both arrays of the
Biomark system, the effects of different PCR components
[HCMV assay; forward primer, reverse primer and probe
(PPP) concentrations; master mixes] on the final quantifi-
cation of each DNA template type was analysed.
Additionally, qPCR, the QX100 system and the 37 K array
were evaluated in terms of linearity, limit of detection
(LOD), LOQ and intraexperiment and interexperiment var-
iability (repeatability). Finally, to gain further knowledge
of the analytical performances of each of these dPCR plat-
forms, two different approaches were used, one consider-





Standard Reference Material 2366 Cytomegalovirus (CMV)
for DNA Measurements, composed of HCMV TowneΔ147
bacterial artificial chromosome DNA, was purchased from
the National Institute of Standards and Technology (USA)
[21]. Initially, 150 μL component C (declared concentration,
19,641 copies per microlitre) was diluted in 1.35 mL 1×
tris(hydroxymethyl)aminomethane–EDTA buffer (Sigma-
Aldrich, USA), and aliquoted and stored at −80 °C [7]. As
the National Institute of Standards and Technology material is
composed of purified plasmid DNA, no further DNA extrac-
tion was needed before its amplification. Because of plasmid
instability reports from the manufacturer, aliquots were tested
for the concentration and stability on the QX100 system by
means of theUL54 assay (UL54 is a DNA polymerase gene of
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HCMV). The mean aliquot concentration (± standard error)
was estimated as 1050 (±30) copies per microlitre (henceforth
indicated as the nominal concentration).
Genomic DNA
The 1st WHO International Standard for Human
Cytomegalovirus for Nucleic Acid Amplification
Techniques was purchased from the National Institute for
Biological Standards and Control (code 09/162) [22]. This
comprised a lyophilized whole-virus preparation of the
HCMV ‘Merlin’ strain. After reconstitution in 1 mL
double-distilled water, the material was additionally dilut-
ed fivefold in phosphate-buffered saline (137 mM NaCl,
2.7 mM KCl, 8 mM Na2HPO4, 2 mM KH2PO4, pH 7.4).
Twenty-two 200-μL aliquots were prepared and extracted
on the same day, using High Pure Viral Nucleic Acid kits
(Roche), according to the manufacturer’s instructions. The
extracted gDNA was then pooled, mixed, aliquoted and
stored at −20 °C. The concentration and stability of the
gDNA were evaluated on the QX100 system by means of
the UL54 assay. The mean nominal concentration was
2580 (±60) copies per microlitre.
Amplification methods
Real-time PCR
The qPCR was performed on a Viia™ 7 Real–Time PCR
System (Life Technologies, USA) according to the
Minimum Information for Publication of Quantitative Real-
Time PCR Experiments (MIQE) guidelines [1] (Table S1).
For the selection of the most variable master mixes, 10-μL
reaction mixtures comprising 3.5 μL DNA sample, 0.5 μL
HCMV assay (the UL54 assay or the UL83 assay; UL83 is
the phosphoprotein pp65 gene of HCMV), and either 3.5 μL
double-distilled water and 2.5 μL 4× master mix (TaqMan®
Fast Virus 1-Step Master Mix; Applied Biosystems, USA) or
1 μL double-distilled water and 5 μL 2× master mix
[TaqMan® Universal PCR Master Mix, Applied Biosystems,
USA; or TaqMan® Gene Expression Master Mix, Applied
Biosystems, USA; or FastStart Universal Probe Master
(Rox), Roche Diagnostics, Switzerland]. Henceforth, each of
these four master mixes are abbreviated, respectively, as ‘Fast
master mix’, ‘Universal master mix’, ‘Gene master mix’, and
‘Roche master mix’. The assessment of the linearity, LOD,
LOQ, and intraexperiment variability and repeatability was
performed with 20-μL reaction mixtures of 8 μL DNA sam-
ple, 1 μL HCMVassay, 6 μL double-distilled water, and 5 μL
4× Fast master mix. For amplification, MicroAmp®
EnduraPlate™ Optical 384-Well Clear Reaction Plates with
Barcode (Life Technologies) were used. The reactions were
conducted under the universal conditions of 2 min at 50 °C,
10 min at 95 °C, and 45 cycles of 15 s at 95 °C and 1 min at
60 °C. Analysis of the data was performed with Viia™ 7
Software version 1.2.4. For each master mix, one negative
template control (NTC) was used.
Droplet-based dPCR
For the QX100 system, all of the reactions were performed
according to the digital MIQE guidelines [23] (Table S2). The
20-μL reaction mixtures consisted of 8 μL sample, 1 μL
HCMV assay, 1 μL double-distilled water, and 10 μL 2×
ddPCR™ Supermix for Probes (Bio-Rad Laboratories,
USA). For each combination of PCR components, the rele-
vant NTCs were included. A QX100™ droplet generator
(Bio-Rad) was used to generate the droplets. The reactions
were performed on the GeneAmp® PCR System 9700 (ABI)
under the same universal conditions as for the qPCR, with the
addition of 10 min at 98 °C. After amplification, the plate was
loaded onto the QX100 system, where analysis of the droplet
fluorescence was done with QuantaSoft Software version
1.3.2.0 (Bio-Rad). The fluorescence was monitored over the
FAM and HEX spectral regions. All of the thresholds were set
up manually to allow the distinction between positive and
negative droplets, and the concentrations of DNA were
Fig. 1 The experimental procedures. Cq quantification cycle, dPCR
digital PCR, HCMV human cytomegalovirus, LOD limit of detection,
LOQ limit of quantification, PPP forward primer, reverse primer and
probe, qPCR real-time PCR
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calculated with Eqs 1, 2, 3 and 4, given later. Only the reac-
tions with more than 10,000 accepted droplets were used for
analysis. As no positive droplets were observed in eight
NTCs, a single positive droplet was enough to determine a
sample as positive.
Microfluidic-based dPCR
For the Biomark system, all of the reactions were performed
according to the digital MIQE guidelines [23] (Table S2). Two
different arrays were used. To test the effects of different PCR
components, the 12.765 array was used with 8-μL reaction
mixtures comprising 3.2 μL sample, 0.4 μL HCMV assay,
0.5 μL 20× GE sample loading reagent (Fluidigm Europe,
The Netherlands) and either 2 μL double-distilled water and
2 μL 4× Fast master mix, or 4 μL 2×master mix (as Universal
master mix, Gene master mix or Roche master mix). To eval-
uate the influence of different PCR components on the 37 K
array, the 4-μL reaction mixtures used comprised 1.4 μL sam-
ple, 0.2 μL HCMV assay, 0.4 μL 20× GE sample loading
reagent, and either 1 μL 4× Fast master mix and 1 μL
double-distilled water, or 2 μL 2× master mix (as Universal
master mix, Gene master mix or Roche master mix). To as-
sess the linearity, LOD, LOQ, and intraexperiment vari-
ability and repeatability on the 37 K array, the 4-μL reac-
tion mixtures comprised 2.4 μL sample, 0.2 μL HCMV
assay, 0.4 μL 20× GE sample loading reagent and 2 μL
4× Fast master mix. The loaded arrays were then trans-
ferred to the Biomark system. The reactions were per-
formed under the same universal conditions as for the
qPCR. The fluorescence was monitored over the FAM
and HEX spectral regions. Data analysis was done with
Biomark™ HD Data Collection Software version 3.1.4,
with manual determination of the fluorescence threshold,
the quality threshold (0.2) and the accepted quantification
cycle (Cq) range (15–45 Cq). As no chambers with am-
plification were observed in six NTCs, one single positive
chamber was enough to determine a sample as positive.
Data processing for dPCR
Several equations were used to calculate the DNA concentra-
tions measured with both of the dPCR platforms, as follows.
The mean number of copies per partition (λ ) was calculat-
ed according to Eq. 1 [23]:




where k is the number of positive partitions, and n is the
number of partitions analysed.
The total reaction volume is the complete volume of the
reaction mix that is transferred into the inlet or the well. The
number of estimated copies per total reaction volume (M) was
calculated according to Eq. 2:
M ¼ λ total reaction volume μLð Þ
partition volume μLð Þ ð2Þ
The effective reaction size is a certain portion of the total
reaction volume that is transferred into the partitions analysed
(chambers or analysed droplets), followed by use of the anal-
ysis software, whereas the rest of the total reaction volume
was excluded from the analysis. The effective reaction size
is the product of the number of the partitions analysed and
their volume [23]. The number of estimated copies per mean
effective reaction size (N) was calculated according to Eq. 3
[23]:
N ¼ λn ð3Þ
The number of estimated copies per 1 μL sample (C) was
calculated according to Eq. 4:
C ¼ d M
sample input volume μLð Þ ; ð4Þ
where d is the dilution of the sample before the analysis.
Determination of the total reaction volume
and the effective reaction size
For each platform, the data for LOD, LOQ, and intraexperiment
variability and repeatability were determined in two ways,
according to either the total reaction volume or the effec-
tive reaction size (Eqs. 1, 2, and 3). For the qPCR, the
total reaction volume was 20 μL, for the 37 K array for
the Biomark system, it was 4 μL, and for the QX100
system, it was 20 μL. On the qPCR platform, in each well
the complete 20-μL reaction was analysed for the fluores-
cence intensity in real time; therefore, the effective reac-
tion size is similar to the total reaction volume. However,
to determine the effective reaction size on the digital plat-
forms, the number of partitions analysed and their volume
need to be defined. For the 37 K array for the Biomark
system, the number of partitions and their volume were
already defined, as each panel contains 770 chambers of
0.84 nL; thus, the effective reaction size was 0.647 μL.
For the QX100 system, the number of partitions analysed
varied between each analysed inlet, and thus it needs to be
determined individually with use of the information from
QuantaSoft Software. In the present study, the number of
accepted droplets ranged from 10,300 to 14,700, with a
mean of 13,600. On the basis of their volume of 0.834 nL
[18], the mean effective reaction size was estimated as
11.3 (±0.8) μL.
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Selection of the most variable master mixes on the qPCR
platform
The qPCR study was initially done to select (1) one master
mix that gave the highest variability for the Cq between the
two HCMV assays; and (2) two master mixes that gave the
highest difference in Cq values for the same HCMVassay. To
achieve high variability, we examined two commonly used
HCMV assays that target different genes and differ in
amplicon size by more than twofold (Table S3). Both the
UL54 assay, which targets a DNA polymerase gene with the
FAM/BHQ hydrolysis probe [24] (Table S3), and the UL83
assay, which targets the phosphoprotein pp65 gene with the
HEX/BHQ hydrolysis probe [25] (Table S3), were used in
combination with each of the four master mixes (i.e., Fast
master mix, Universal master mix, Gene master mix and
Roche master mix). Both of these HCMV assays were used
with 600 nM primers and 100 nM probes. To determine the
PCR efficiency, each combination of HCMVassay and master
mix was tested in duplicate, with either 1× diluted plasmid
DNA and 5× diluted plasmid DNA, or 2.5× diluted gDNA
and 12.5× diluted gDNA. A single NTC was performed for
each combination of HCMVassay and master mix.
Influence of different PCR components on DNA
quantification by dPCR
For both of the dPCR platforms, each DNA template type was
used and different PPP concentrations were tested with each
HCMVassay (i.e.,UL54 andUL83). For the Biomark system,
the Fast master mix and Universal master mix were used for
the analysis, whereas for the QX100 system, the supermix for
probes was used, as the only suitable master mix that allowed
droplet stabilization. For the 12.765 array for the Biomark
system, three different PPP concentrations (i.e., 300/300/100
nM, 600/600/200 nM, and 900/900/200 nM) were used with
each combination of DNA template type, HCMV assay and
master mix. For the 37 K array for the Biomark system, only
the lowest two of these PPP concentrations were used. For the
12.765 array, the mixtures for duplicate reactions were com-
posed of either 4.5× diluted plasmid DNA or 10× diluted
gDNA (λ ~ 0.6 for each), whereas for the 37 K array, the
mixtures for duplicate reactions comprised either 1× diluted
plasmid DNA or 2× diluted gDNA (λ ~ 0.35 for each).
For the QX100 system, six different PPP concentrations
(i.e., 300/300/100 nM, 300/300/200 nM, 600/600/100 nM,
600/600/200 nM, 900/900/100 nM, and 900/900/200 nM)
were used with each combination of DNA template type and
HCMVassay. The analyses were performed in duplicate with
either 5× diluted plasmid DNA or 12.5× diluted gDNA (λ ~
0.07 for each). For each combination of PCR components, a
single NTC was performed.
Linearity, LOD, LOQ, and intraexperiment variability
and repeatability on the qPCR and dPCR platforms
For the qPCR and both of the digital platforms, a single PPP
concentration (i.e., 600/600/200 nM) in the UL54 assay was
used with Fast master mix (for qPCR and the 37 K array) or
supermix for probes (for QX100) to quantify the dilution se-
ries of the gDNA. Fast master mix was selected for this, as it
was more concentrated and therefore allowed higher volumes
of sample input into the 37 K array inlets in comparison with
the other three, less concentrated master mixes, whereas with
the UL54 assay, better data were obtained with the selected
master mix in comparison with the UL83 assay. To assess the
qPCR and the QX100 system, 12 different dilutions of gDNA
were used (starting from a 3.76× dilution), whereas the 37 K
array for the Biomark system was tested with nine different
gDNA concentrations (starting from a 1× dilution) (Tables S4,
S5, S6). Additionally, for each platform, three to five NTCs
were tested in each experiment. For the qPCR, the data from
the dilution-series measurements from both days were com-
bined and used to generate the standard curve, which allowed
the calculation of the DNA concentrations for each individual
measurement. The complete assessment was performed by
one operator on two consecutive days, with five replicates of
each dilution per day. The dilution series were freshly pre-
pared on the day of analysis. To eliminate bias caused by
possible unequal pipetting volumes during the sample mixing
with the reaction mix, larger volumes of reaction mix and
sample were mixed together, followed by the aliquoting of
this mixture into five wells or inlets. For every dilution on
each quantification platform, the nominal and measured mean
M, N and λ were calculated (Tables S4, S5, S6).
Statistical analysis
The statistical analysis of the influence of the different PCR
components on the DNA quantification was performed by
single-factor analysis of variance and Student’s t tests (two
tailed, two sample equal variance) in Microsoft Excel 2007.
For the determination of outliers, Grubbs’s test (95 % confi-
dence level) was used in Microsoft Excel 2007.
For assessment of linearity, LOD, LOQ and intraexperiment
variability and repeatability, single-factor analysis of variance
and Student’s t tests were used to determine the statistical sig-
nificance of the bias between the nominal and measured con-
centrations. For each platform, intraexperiment linearity (five
replicates from 1 day) and interexperiment linearity (ten repli-
cates, five from each of 2 days) were analysed by means of
Pearson’s correlation coefficients (R studio version 0.98.977).
Outliers were not determined, to retain the complete variability
of the data. For each platform, the LOD with a 95 % confi-
dence interval was determined with Probit software, for which
the interexperiment data were taken into account [26]. For each
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nominal DNA concentration, the coefficient of variation (CV)
was calculated for either five or ten replicates, according to
Eq. 5:
CV ¼ standard deviation
average concentration
ð5Þ
The CVs for each platform were plotted against the nomi-
nal concentrations (in terms of either copies per total reaction
volume or copies per effective reaction size) (R studio version
0.98.977). For each platform, the LOQ based on the
interexperiment data was determined as the lowest nominal
DNA concentration where the CV was still below 25 %
[27]. The predicted Poisson error, expressed as the theoretical
CV, was calculated for both of the dPCR platforms according
to Eq. 6, as based on Poisson statistics [6]:







Real-time PCR: high variability of Cq values obtained
with different PCR components
The initial qPCR study was performed with the two HCMV
assays (i.e., UL54 and UL83) and the four master mixes (i.e.,
Fast master mix, Universal master mix, Gene master mix and
Roche master mix) on the plasmid DNA and gDNA, to select
two master mixes for further testing for the Biomark platform
(Fig. 2). The master mixes were selected according to the
highest variability in Cq values between different HCMVas-
says and/or between different master mixes for the same
HCMV assay. With each DNA template, Universal master
mix demonstrated the largest differences in Cq values between
the two HCMV assays. With the plasmid DNA, the fluores-
cence of the UL54 assay reached the fluorescence threshold
(Cq) 2.5 cycles before that of theUL83 assay (Fig. 2a), where-
as when gDNA was used, between the two HCMV assays
there was a difference of 4 in the Cq values (Fig. 2b). With
each DNA template, the other three master mixes gave only
small differences in Cq values between the two HCMVassays
(difference in Cq values, 0.1–0.7).
With the UL83 assay, the largest differences in Cq values
were observed with Fast master mix and Universal master mix
(difference in Cq values, plasmid DNA 1.9, gDNA 3.1),
whereas with the UL54 assay, the largest differences were
observed between Universal master mix and Gene master
mix (difference in Cq values, plasmid DNA 1.7, gDNA 1.7)
(Fig. 2). According to the data obtained, Fast master mix and
Universal master mix were selected for further testing of the
influence of different PCR components on DNA quantifica-
tion for the Biomark system.
Digital-PCR-based quantification shows resilience
to the different PCR components
For both of the dPCR platforms, these assessments were per-
formed with plasmid DNA and gDNA with the two HCMV
assays with different PPP concentrations and both of the se-
lected master mixes (Biomark) or supermix for probes
(QX100). For each dPCR platform, there was little influence
of the different PCR components on the DNA quantification
(Figs. 3, 4).
On both arrays for the Biomark system, significant differ-
ences between the data were rarely observed (Fig. 3). With
plasmid DNA for the 12.765 array (Biomark), the use of
Universal master mix resulted in increased copy-number esti-
mations (by 19 %) compared with Fast master mix, regardless
of the HCMVassay or PPP concentrations (p<0.01) (Fig. 3a).
On the same array, differences were also observed with
gDNA, as the UL54 assay gave 15 % higher copy-number
estimations than the UL83 assay, regardless of master mix or
PPP concentrations (p<0.001) (Fig. 3b).
Fig. 2 Effects of the different
HCMVassays and master mixes
on the Cq values for qPCR, with
use of circular plasmid DNA (a)
and genomic DNA (b). In a single
run, each template type was
amplified with each combination
of HCMVassay and master mix,
in duplicate
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On the other hand, with the low PPP concentrations tested
on the 37 K array in combination with the UL83 assay, Fast
master mix and gDNA, significant 37 % higher copy-number
estimations were observed when compared with the estima-
tions obtained when high PPP concentrations were tested
(p<0.001) (Fig. 3d). For each array, all of the other combina-
tions of HCMV assay, PPP concentrations, master mixes and
DNA templates did not show any statistically significant ef-
fects on the final copy-number estimations (p>0.05).
Additionally, on both arrays for the Biomark system, no out-
liers were detected. Furthermore, although there were up to
twofold differences in the fluorescence intensities between
the different PPP concentrations, and up to 2.5 Cq differences
between the different HCMV assays and master mixes, there
were no correlations with the previously mentioned significant
differences in DNA copy-number estimations (Figs. S1, S2).
For the QX100 system with the UL54 assay with gDNA,
20 % higher copy-number estimations were observed in com-
parison with the UL83 assay, regardless of the PPP concentra-
tions (p<0.001) (Fig. 4b), whereas with plasmid DNAno such
difference was found (Fig. 4a). Using the UL54 assay with
both of these DNA templates, we observed higher fluores-
cence intensities compared with those we observed when we
used the UL83 assay; however, both of these HCMV assays
allowed simple manual threshold settings. With the different
PPP concentrations, almost twofold differences in the fluores-
cence intensities of the droplets were observed (Fig. S3);
however, there were no significant influences on the copy-
number estimations (p>0.05) (Fig. 4).
Linearity, LOD, LOQ and intraexperiment variability
and repeatability
For each platform, the linearity, LOD, LOQ and intraexperiment
variability and repeatability were determined by means of serial
dilutions of gDNA and one PPP concentration of the UL54
assay, with either Fast master mix (qPCR and 37 K array) or
supermix for probes (QX100). These measurements were per-
formed over two consecutive days, with five replicates on each
day.
Linearity
Linear response above the LOD was observed, whereas for
qPCR (measured linear dynamic range 5.5–5490 copies per
total reaction volume), the Biomark system (measured linear
dynamic range 33–6190 copies per total reaction volume) and
the QX100 system (measured linear dynamic range 11–5490
copies per total reaction volume) (Fig. 5, Fig. S4), however,
the upper dynamic range was not experimentally determined
as high viral loads are not clinically relevant. On each dPCR
platform, there was better correlation with nominal gDNA
concentration (R2>0.998) in comparison with correlation on
the qPCR platform (R2>0.987) (Fig. 5, Fig. S4).
Fig. 3 Influence of the different
PCR components on the copy-
number estimations for the
Biomark system for the 12.765
array (a, b) and the 37 K array
(c, d), with use of circular plasmid
DNA (a, c) and genomic DNA
(b, d). For each combination of
HCMVassays and master mix,
three (a, b) and two (c, d)
different primer and probe
concentrations were used (as
indicated), with all experiments
done in duplicate. cp copies
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LOD, LOQ and intraexperiment variability
and repeatability
On each platform, the data were assessed with two approaches,
one based on the total reaction volume and the other based on
the effective reaction size. When the total reaction volume was
considered, the lowest LOD and lowest LOQwere obtained for
qPCR, as the analysis indicated reliable detection and quantifi-
cation of three and 11–22 copies, respectively (Table 1). For the
QX100 system, the LOD was around six copies and the LOQ
around 55 copies, whereas the 37 K array for the Biomark
system showed the highest LOD (14 copies) and LOQ (140–
190 copies) (Table 1). The qPCR platform and the QX100
system showed lower intraexperiment variability and higher
repeatability in comparison with the 37 K array for the
Biomark system (Fig. 6a, b). Furthermore, for qPCR, for con-
centrations below 55 copies, less variable data were obtained
than for the QX100 system.
In contrast, considering the effective reaction size on all
three platforms, similar LODs were estimated (at around three
Fig. 4 Influence of the different PCR components on the copy-number
estimations for the QX100 system, with use of circular plasmid DNA (a)
and genomic DNA (b). For each combination of HCMV assays and
primer and probe concentrations, duplicates were used. cp copies
Fig. 5 Interexperiment linearity for qPCR (a), the QX100 system (b), and
the 37 K array for the Biomark system (c). DNA concentrations below the
LODs were omitted from the plot. Each concentration of genomic DNA
was measured in ten replicates, five from each of the 2 days. cp copies
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copies). For concentrations above 55 copies, the repeatability
for the dPCR platforms was equal to or better than that of
qPCR. However, qPCR with concentrations between 10 and
55 copies showed the lowest LOQ, the lowest intraexperiment
variability, and the highest repeatability (Fig. 6c, d).
On each platform, LODs equal to or lower than the theo-
retical LOD were observed (Table 1). On the other hand, on
both of the dPCR platforms, the CV and LOQ from both the
intraexperiment data and the interexperiment data were higher
than the theoretical values (Table 1, Fig. 6).
Concordance between the platforms
On the qPCR platform and the QX100 system, inconsistent
copy-number estimations were obtained throughout the dy-
namic range. On the qPCR platform, the copy-number esti-
mations ranged from 14 % lower to 19 % higher than expect-
ed, whereas for the QX100 system, the estimations ranged
from 12 % lower to 13 % higher than expected (Tables S4
and S6). For the Biomark system, very consistent copy-
number estimations were obtained, which ranged from 19 to
26 % higher than expected (Table S5).
Cost-effectiveness and time-effectiveness for routine diagnosis
of viruses and microorganisms
Clinical applicability of different platforms for routine di-
agnosis of HCMV and other pathogens also depends on
their cost-effectiveness and time-effectiveness. Therefore,
all three platforms were assessed in terms of relative final
price per sample (consumables, labour fee and indirect
costs), hands-on time and turnaround time to conduct the
analysis for different numbers of samples (Table 2).
Irrespective of the number of samples analysed, qPCR
was the most cost-effective and time-effective. The
QX100 system was more suitable for routine analysis than
any array of the Biomark system, whereas 37 K array is
more applicable for routine diagnosis than the 12.765 ar-
ray. Additionally, in Slovenia, the price for the Biomark
instrument is four to five times higher than that for qPCR
instruments, whereas the cost of the QX100 instrument is
up to two times higher than that of qPCR instruments.
Discussion
Digital PCR (dPCR) is becoming more and more recog-
nized in molecular biology measurements for different ap-
plications, bringing new perspectives for absolute quanti-
fication of nucleic acids. Although some aspects of dPCR
have already been investigated, in comparison with the
present-day ‘gold standard’ of qPCR, there remains the
need for further detailed evaluation and optimization of
the analytical steps in dPCR procedures, to support accu-
rate and reliable quantification of nucleic acids. In the pres-
ent study, the assessment included qPCR, the QX100 sys-
tem, and two different arrays for the Biomark system, with
use of HCMV DNA, as accurate HCMV DNA quantifica-
tion is of paramount importance for effective disease con-
trol [28, 29].
Different PCR components are known to have significant
influences on the efficiency of qPCR, which can lead to dif-
ferent Cq values [30]. However, according to end-point mea-
surements, dPCR has been reported to be more tolerant to
differences in PCR efficiency than qPCR, which should thus
result in little variation or no variations in copy-number esti-
mations when different PCR components are used [8]. In the
present study, two dPCR platforms were assessed for different
combinations of HCMV assays and selected master mixes,
which strongly influenced qPCR efficiency. Here, each
dPCR platform showed low susceptibility to the influence of
the different PCR components on the final copy-number
estimations.
For the Biomark system, despite some minor effects of
different HCMV assays, master mixes and PPP concentra-
tions that altered the final copy-number estimations, these
effects were never consistent for both DNA templates or
both array types. Furthermore, these minor effects were
probably not hampered by low PCR efficiency, which
indicated that there are other causes for the observed
Table 1 Limit of detection (LOD) and limit of quantification (LOQ) for
real-time PCR (qPCR) and both digital PCR (dPCR) platforms according
to the reaction volume analysis. Only the interexperiment variability
(repeatability) was taken into account. The LOD was calculated with
Probit software. The LOQ was determined as the lowest concentration
for which the coefficient of variation was below 25 %. The expected
LODs and LOQs are in parentheses
Analysis method Copy number according to analysis system
qPCR QX100 Biomark
LOD LOQ LOD LOQ LOD LOQ
Total reaction volume 2.8 (3) 11–22 5.7 (5.3) 55 (28) 14 (18) 140–210 (100)
Effective reaction size 2.8 (3) 11–22 3.2 (3) 30 (16) 2.4 (3) 14 (18)
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differences in copy-number estimations. Little influence
of different HCMV assays has already been reported [2,
6], which can be explained as a consequence of the dif-
ferent rates of molecular dropout for different HCMV as-
says [8, 31, 32]. Minor variability between different mas-
ter mixes is also in agreement with previous reports,
where differences of up to 50 % were observed [6, 32].
This can be explained by different influences of the mas-
ter mixes, which can facilitate either molecular dropout or
linkages between DNA templates, therefore increasing the
proportion of partitions with more than one template, and
consequently reducing the final copy-number estimation
[8].
For the QX100 system, low susceptibility to different
HCMV assays confirmed a previous observation [33].
However, the low influence of different HCMV assays
might be caused by different degrees of molecular dropout,
as already seen in our study on the 12.765 array for the
Biomark system and in other reports [6]. In a study con-
ducted on qPCR, the amplicon size was found to be in-
versely correlated with analytical sensitivity of qPCR
[34]. Therefore, it could be speculated that the twofold
difference in amplicon size between the two HCMVassays
used in our study might be the major cause for the different
rates of molecular dropout observed on each dPCR plat-
form, since because of fragmented HCMV DNA, bigger
amplicons are less likely to find an intact DNA fragment.
High robustness of the QX100 system has already been
confirmed, and this system can be efficiently used for
multiplexing with varying PPP concentrations without
hampering the quantification repeatability [35]. However,
our finding is discrepant with that of a previous report,
where there was a 66 % increase with the lower PPP con-
centrations compared with the higher PPP concentrations
[20]. The main reason for the lower robustness in that pre-
vious report in comparison with the present findings might
be the combination of small differences in the fluorescence
intensities between the clusters of positive and negative
droplets seen on the plots, and the high number of droplets
with intermediate fluorescence (i.e., the ‘rain’), which was
probably the result of either delayed amplification (i.e., the
Monte Carlo effect) or differences in PCR efficiency of the
particular assay [19]. It is reasonable to assume the combi-
nation of both of these factors might cause difficult dis-
crimination between negative and positive droplets, partic-
ularly when low PPP concentrations are used, which would
therefore hamper the decision on the final threshold setting
and lead to overestimation or underestimation of the DNA
copy numbers. Consequently, this might result in higher
variability between different PPP concentrations. In con-
trast, the PCR efficiencies in the present study were near
optimal for both of the HCMVassays, as the large increase
in fluorescence intensities of the positive droplets and the
Fig. 6 Intraexperiment variability (a, c) and repeatability (b, d) for all
three of the platforms according to the total reaction volume (a, b) and the
effective reaction size (c, d). The data are the coefficients of variation for
five measurements on each day (a, c), or for ten combined measurements
from 2 days (b, d). For each genomic DNA concentration, five replicates
were measured on two consecutive days. Blue line theoretical coefficient
of variation for the QX100 system (with 14,000 accepted droplets), green
line theoretical coefficient of variation for the 37 K array for the Biomark
system (with 770 chambers), dashed line criterion for the limit of
quantification, set at a coefficient of variation of 25 %
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small amount of rain resulted in straightforward setting of
the threshold. Therefore, the degree of dPCR robustness
might be closely related to general PCR efficiency of a
particular HCMV assay, as efficient assays facilitate the
distinction between the positive and the negative droplets,
and are therefore more robust than assays with low effi-
ciency [19].
When the assessment of linearity and variability was
performed, between all three of these platforms, there
was high agreement in the DNA copy-number estimations,
although different PCR-based quantification techniques
were compared. The highest agreement was noted between
qPCR and the QX100 system. In theory, the qPCR estima-
tion accuracy and agreement with estimations on dPCR
usually depend on the choice of the method for quantifica-
tion of the calibration material, and the commutability of
the calibrant with the test samples when specific combina-
tions of HCMV assay and master mix are used [29].
Consequently, compared with dPCR, qPCR can produce
more than 50 % higher or lower DNA copy-number esti-
mations [2, 7, 36]. In the present study, the agreement
between qPCR and the QX100 system was high probably
because of the use of gDNA that was initially quantified
with the QX100 system, and that was used on the qPCR
plaform as both the calibration material and the testing
material, thus eliminating any reason for suboptimal
commutability.
High agreement was also observed between the dPCR
platforms; however, the Biomark system constantly gave
higher copy-number estimations than the QX100 system.
Good interplatform reproducibility of different dPCR plat-
forms has already been documented in two previous
assessmentes that compared the 37K array and 12.765
array for the Biomark system with the QX100 system
[6, 18]. Although the Biomark system gave 8 % and
30 % higher estimations than the QX100 system, it is
difficult to determine which platform, if any, provides
the most accurate copy-number estimations. Therefore,
either the overestimation of the DNA copy number for
the Biomark system or the underestimation for the
QX100 system, or the combination of both, should be
taken into account. For the Biomark system, overestima-
tion of DNA copy number could be due to either under-
estimation of chamber volumes on the 37 K array (based
on Eq. 1) or the occurrence of single-stranded-DNA mol-
ecules during partitioning [8, 17, 32]. On the other hand,
for the QX100 system, underestimation of the DNA copy
number can be explained through several causes. As dif-
ferent master mixes were used on the dPCR platforms, the
one used for the QX100 system might be associated with
higher rates of molecular dropout and template linkages
during partitioning. Additionally, improperly estimated
partition volumes and their variability would also cause
underestimation [8]. As only low mean partition occupan-
cies were used in the present study for QX100, the impact
of intracartridge partition variability should be negligible
[8]. In contrast, overestimation of the mean droplet vol-
ume might have a bigger impact on the underestimation of
Table 2 Comparison of
cost-effectiveness and time-
effectiveness between three









1 Relative final price per sample (%)b 100 1339 614 137
Hands on time (h) 1 1.2 1.4 1.25
Total turnaround time (h) 2.8 3.2 4 3.5
5 Relative final price per sample (%)b 100 998 459 173
Hands on time (h) 1.1 1.4 1.5 1.5
Total turnaround time (h) 2.9 3.4 4.1 4
20 Relative final price per sample (%)b 100 2110 271 207
Hands on time (h) 1.4 5.6 1.8 2
Total turnaround time (h) 3.2 13.6 4.3 5
45 Relative final price per sample (%)b 100 2390 296 254
Hands on time (h) 1.7 11.2 2.2 3
Total turnaround time (h) 3.5 27.2 8.6 6.5
a For each analysis, every sample was estimated to be tested in duplicate, together with one negative template
control and either a standard curve composed of five dilutions tested in duplicate (qPCR) or one positive control
(both dPCR platforms)
b For the purpose of comparison, the final price per sample for qPCR analysis of 1, 5, 20, or 45 samples was taken
as a reference with an assigned value of 100 %. Final prices were calculated on the basis of costs in Slovenia and
include consumables, labour fees and indirect costs. Costs related to DNA extraction were excluded from the
calculations
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the DNA copy numbers, as the estimated copy numbers
are inversely related to the partition volume (Eq. 3). As
the mean droplet volume ranges from 0.83 to 0.91 nL
between laboratories and cartridges [3, 18, 37], different
performances of droplet generators can be speculated.
Restricted sample volume input is considered the major
factor for the superior analytical sensitivity of qPCR over
dPCR [7, 9]. In the present study, qPCR was more sensi-
tive than both of the dPCR platforms, which is in agree-
ment with most other assessments [7, 9, 36]. However,
equal LODs for qPCR and the QX100 system have also
been reported [11]. Interestingly, the equal sample vol-
umes used for qPCR and the QX100 system indicate that
the restricted volume is probably not the only cause of the
higher LOD for dPCR. Taking into account perfect assay
specificity, the sample volume analysed must on average
contain at least three copies to meet the criterion for the
theoretical LOD (with 95 % probability) [1]. However,
the volumetric difference between the initial sample input
and the analysed sample volume (i.e., the effective reac-
tion size) should also be taken into account when one is
determining the theoretical LOD for the total reaction vol-
ume. Although in terms of the effective reaction size, on
all three platforms the LOD was equal to the theoretical
LOD, when the total reaction volume was considered,
with both dPCR platforms higher LODs than with the
qPCR platform were observed.
To our knowledge, this is the first comparison of the
QX100 system and the 37 K array on the Biomark system
in terms of linearity, analytical sensitivity and LOQ. Here,
with respect to the total reaction volume when low con-
centrations were used (fewer than 1000 copies per total
reaction volume), we indicate the dominant performance
of the QX100 system in terms of LOD, LOQ and
intraexperiment variability and repeatability. However,
when the effective reaction size was considered, both plat-
forms showed similar LOD, LOQ and intraexperiment
variability and repeatability, although for the QX100 sys-
tem, more than a 15-fold higher number of partitions was
analysed. Furthermore, on both dPCR platforms, these
data were also in agreement with the comparisons of the-
oretical CVs. Our findings strongly suggest that when the
total reaction volume is considered, with low DNA con-
centrations, the variability of the dPCR platform is influ-
enced not by the number of partitions analysed but by the
ratio between the effective reaction size and the total re-
action volume.
When the total reaction volume is considered, both dPCR
platforms have been reported to show lower intraexperiment
variability and higher repeatability throughout the entire dy-
namic range, in comparison with qPCR [2, 5, 9, 33]; however,
such a trend was not observed in the present study. As the
theoretical variability of dPCR is based on the Poisson
distribution and can thus be mathematically predicted
(Eq. 5), the qPCR variability is additionally dependent on
the PCR efficiency and the instrument used, and conse-
quently the variability is less predictable and is usually
larger than the variability of dPCR [1, 23]. However, when
the effective reaction size is considered, in the present
study the variability of qPCR was not considerably higher
that the theoretical variability of dPCR, which indicates
low inhibition and only minor effects on amplification ef-
ficiency. As a result, when the total reaction volume is
considered, the variability of qPCR was equal to, or even
lower than, the theoretical variability of each of the dPCR
platforms, probably due to the larger effective reaction size
of qPCR. In addition, each dPCR platform showed higher
variability than theoretically expected, which might also
explain the slightly better performance of qPCR in com-
parison with both dPCR platforms, even when the effective
reaction size was taken into account.
On both dPCR platforms, besides the matrix and HCMV
assay effects, another source of higher variability than theo-
retically expected can be considered. On all three platforms, a
certain sample volume is transferred from the tube into the
wells or inlets, which acts as the first stochastic event. In
addition, on both dPCR platforms, only certain parts of the
total reaction volume are distributed from the wells or inlets
into the chambers or droplets analysed, which is considered
the second stochastic event. Therefore, when low DNA con-
centrations are used, it is reasonable to assume that unequal
distribution of DNA templates during the additional stochastic
events on the dPCR platforms might increase the variability.
Despite a more than 20-fold difference in the analysed reac-
tion volume between both dPCR platforms during the second
stochastic event, equal variability was observed for both
dPCR platforms when the effective reaction size was consid-
ered. This could indicate no or only a minor influence of the
analysed reaction volume on the final variability, when a re-
action volume of at least 0.64 μL is analysed. Nevertheless,
additional statistical analysis should be done to confirm both
hypotheses.
On both dPCR platforms, several approaches can be
used to circumvent either small effective reaction sizes or
restricted sample volumes. Although both of the arrays for
the Biomark system have a constant effective reaction size
because of fixed numbers of chambers on the array, the
mean numbers of accepted droplets for the QX100 and
QX200 systems vary, and will usually reach only 60–
75 % of the initial 20,000 droplets [5, 11, 33]. Therefore,
optimization of the pipetting techniques during the droplet
transfer might increase the number of droplets accepted,
which would theoretically result in an increased effective
reaction size. Alternatively, the use of replicates might in-
crease the effective reaction size analysed, and thus en-
hance the final sensitivity and repeatability [1].
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For routine diagnosis of microorganisms and viruses,
qPCR has been shown to be the most cost-effective and
time-effective platform, which is in agreement with other
studies [38, 39]. The minor differences in estimations of
cost-effectiveness and time-effectiveness for qPCR and the
QX100 system between the reports mentioned and our calcu-
lations are probably due to different prices for consumables,
labour fees and indirect costs between countries, and different
optimization of analysis protocols in terms of time.
Conclusions
To the best of our knowledge, the present study represents the
first assessment of the two most commonly used dPCR plat-
forms, the QX100 system and both of the arrays for the
Biomark system, performed in terms of the susceptibility to
different PCR components when viral DNA is used.
Additionally, we have reported the first evaluation of qPCR
and both of the dPCR platforms in terms of linearity, LOD,
LOQ and intraexperiment variability and repeatability, while
considering both the total reaction volume and the effective
reaction size. For the QX100 system and the Biomark system,
there was only minor susceptibility to the different PCR com-
ponents that hampered the qPCR assay efficiencies, thus
confirming the high tolerance of dPCR. In addition, both of
the dPCR platforms showed high interplatform agreement even
in the low dynamic range of viral DNA concentrations. Minor
discrepancies between different dPCR platforms might be fur-
ther minimized if additional metrological studies to evaluate
the partition volumes are performed. High resilience to inhib-
itors, assays with suboptimal efficiency and good reproducibil-
ity of different dPCR platforms might further indicate their
potential suitability as higher-order reference measurement
methods and as the methods for value assignment of reference
materials [28]. Additionally, both dPCR platforms might be
beneficial in the field of clinical diagnostics, especially when
interlaboratory standardization of the qPCR-measured viral
loads is limited by noncommutable standard materials [28].
Although the QX100 system, and especially the 37 K array
for the Biomark system, reduced the applicability for quantifi-
cation of low DNA concentrations because of the smaller ef-
fective reaction sizes compared with those in qPCR, the use of
replicates and the optimization of pipetting techniques should
help to increase their usefulness for such applications.
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